MDSpire - Summary
Feature

PFAS Exposure Linked to Faster Epigenetic Aging 

Epigenetic clock analysis ties PFNA exposure to faster biological aging, particularly in men aged 50–64 

  • April 1, 2026

  • 2 min

Share

Recent research has established a link between lesser-studied PFAS compounds, specifically PFNA and perfluorooctane sulfonamide, and accelerated epigenetic aging in U.S. adults aged 50 to 64. The study analyzed archived data from 326 participants, revealing that 95% had detectable levels of these PFAS in their blood. Notably, PFNA was associated with significant epigenetic aging, particularly in men, suggesting that lifestyle factors may exacerbate health risks. The findings urge a reevaluation of the impact of newer PFAS compounds on aging and health.

Original Source(s)

PFAS Exposure Linked to Faster Epigenetic Aging 

  • April 1, 2026

Related Content

FDA Approves Lilly’s Foundayo Oral GLP-1 Pill

The newly approved therapy offers a noninjectable option that can be taken at any time of day without food or water restrictions.

Prednisolone Linked to Metabolic Benefits

A randomized crossover trial found slower bone turnover and no safety differences compared with standard hydrocortisone regimens

Your Biological Age? It's in the Blood

Multi-marker model may refine risk prediction and preventive testing

  • April 1, 2026

  • 2 min